1. Whither peptide receptor radionuclide therapy for neuroendocrine tumors: an Einsteinian view of the facts and myths

   • Vikas Prasad
   • Lisa Bodei
   • Irvin M. Modlin

   Editorial 08 May 2014 Pages: 1825 - 1830

2. Assessment of predictors of response and long-term survival of patients with neuroendocrine tumour treated with peptide receptor chemoradionuclide therapy (PRCRT)

   • G. Kong
   • M. Thompson
   • Rodney J. Hicks

   Original Article Open access 21 May 2014 Pages: 1831 - 1844

   

3. 177 Lu-Dota-octreotate radionuclide therapy of advanced gastrointestinal neuroendocrine tumors: results from a phase II study

   • Giovanni Paganelli
   • Maddalena Sansovini
   • Dino Amadori

   Original Article 11 March 2014 Pages: 1845 - 1851

   

4. The combination of FDG PET and dynamic contrast-enhanced MRI improves the prediction of disease-free survival in patients with advanced breast cancer after the first cycle of neoadjuvant chemotherapy

   • Ilhan Lim
   • Woo Chul Noh
   • Sang Moo Lim

   Original Article 14 June 2014 Pages: 1852 - 1860

   

5. Twelve-year experience of radioembolization for colorectal hepatic metastases in 214 patients: survival by era and chemotherapy

   • Robert J. Lewandowski
   • Khairuddin Memon
   • Riad Salem

   Original Article 07 June 2014 Pages: 1861 - 1869

   

6. Correlation between ¹⁸F-fluoromisonidazole PET and expression of HIF-1α and VEGF in newly diagnosed and recurrent malignant gliomas

   • Nobuyuki Kawai
   • Wei Lin
   • Takashi Tamiya

   Original Article 30 April 2014 Pages: 1870 - 1878

   

7. [¹⁸F]Fluciclatide in the in vivo evaluation of human melanoma and renal tumors expressing α_vβ₃ and α_vβ₅ integrins

   • Esther Mena
   • Rikard Owenius
   • Karen Kurdziel

   Original Article 28 June 2014 Pages: 1879 - 1888

   

8. Value of ¹⁸F-FDG uptake on PET/CT and CEA level to predict epidermal growth factor receptor mutations in pulmonary adenocarcinoma

   • Kai-Hsiung Ko
   • Hsian-He Hsu
   • Hung Chang

   Original Article 23 May 2014 Pages: 1889 - 1897

   

9. The role of metabolic tumor volume and total lesion glycolysis on ¹⁸F-FDG PET/CT in the prognosis of epithelial ovarian cancer

   • Jeong Won Lee
   • Arthur Cho
   • Won Jun Kang

   Original Article 23 May 2014 Pages: 1898 - 1906

   

10. Anti-L1CAM radioimmunotherapy is more effective with the radiolanthanide terbium-161 compared to lutetium-177 in an ovarian cancer model

    • Jürgen Grünberg
    • Dennis Lindenblatt
    • Roger Schibli

    Original Article 24 May 2014 Pages: 1907 - 1915

    

11. Diagnostic value of FDG-PET/(CT) in children with fever of unknown origin and unexplained fever during immune suppression

    • Gijsbert J. Blokhuis
    • Chantal P. Bleeker-Rovers
    • Lioe-Fee de Geus-Oei

    Original Article 29 May 2014 Pages: 1916 - 1923

    

12. ¹⁸F-fluorodeoxyglucose positron emission tomography combined with whole-body computed tomographic angiography in critically ill patients with suspected severe sepsis with no definite diagnosis

    • Damien Mandry
    • Alexis Tatopoulos
    • Sébastien Gibot

    Original Article 22 May 2014 Pages: 1924 - 1930

    

13. Differences in striatal dopamine transporter density between tremor dominant and non-tremor Parkinson’s disease

    • Valtteri Kaasinen
    • Maija Kinos
    • Tommi Noponen

    Original Article 28 May 2014 Pages: 1931 - 1937

    

14. Extrastriatal binding of [¹²³I]FP-CIT in the thalamus and pons: gender and age dependencies assessed in a European multicentre database of healthy controls

    • Walter Koch
    • Marcus Unterrainer
    • Christian la Fougère

    Original Article 08 May 2014 Pages: 1938 - 1946

    

15. ¹¹C-ORM-13070, a novel PET ligand for brain α_2C-adrenoceptors: radiometabolism, plasma pharmacokinetics, whole-body distribution and radiation dosimetry in healthy men

    • Pauliina Luoto
    • Sami Suilamo
    • Juha O. Rinne

    Original Article 17 May 2014 Pages: 1947 - 1956

    

16. Safety of ventilation/perfusion single photon emission computed tomography for pulmonary embolism diagnosis

    • Pierre-Yves Le Roux
    • Xavier Palard
    • Pierre-Yves Salaun

    Original Article 10 April 2014 Pages: 1957 - 1964

    

17. ^99mTc-MAA overestimates the absorbed dose to the lungs in radioembolization: a quantitative evaluation in patients treated with ¹⁶⁶Ho-microspheres

    • Mattijs Elschot
    • Johannes F. W. Nijsen
    • Hugo W. A. M. de Jong

    Original Article 13 May 2014 Pages: 1965 - 1975

    

18. The evidence base for the use of internal dosimetry in the clinical practice of molecular radiotherapy

    • Lidia Strigari
    • Mark Konijnenberg
    • Glenn Flux

    Review Article 11 June 2014 Pages: 1976 - 1988

    

19. Erratum to: Value of ¹⁸ F-FDG uptake on PET/CT and CEA level to predict epidermal growth factor receptor mutations in pulmonary adenocarcinoma

    • Kai-Hsiung Ko
    • Hsian-He Hsu
    • Hung Chang

    Erratum 08 July 2014 Pages: 1989 - 1990

    

20. Simone Waldt and Klaus Woertler (Eds): Measurements and Classifications in Musculoskeletal Radiology

    • Giuseppe D. Di Stasio
    • Luigi Mansi

    Book Review 27 May 2014 Pages: 1991 - 1991

21. Richard B. Gunderman: Essential Radiology: Clinical Presentation, Pathophysiology, Imaging (3rd edn.)

    • Davide D’Arienzo
    • Luigi Mansi

    Book Review 30 July 2014 Pages: 1992 - 1992

22. Mycotic aneurysm of the superior mesenteric artery and other sequelae of prosthetic valve endocarditis on ¹⁸F-FDG PET/CT

    • Eugene J. Teoh
    • Laura Backhouse
    • Kevin M. Bradley

    Image of the Month 04 June 2014 Pages: 1993 - 1994

    

23. Nuclear medicine training and practice in Poland

    • Anna Teresińska
    • Bożena Birkenfeld
    • Mirosław Dziuk

    UEMS/EBNM Open access 05 August 2014 Pages: 1995 - 1999

24. The 8th International Congress of the Croatian Society of Nuclear Medicine: highlights from Šibenik, 9–12 May 2014

    • A. T. Golubić
    • D. Huić

    Society Communications 23 August 2014 Pages: 2000 - 2003